206 related articles for article (PubMed ID: 22048692)
1. Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies.
Kacskovics I; Cervenak J; Erdei A; Goldsby RA; Butler JE
MAbs; 2011; 3(5):431-9. PubMed ID: 22048692
[TBL] [Abstract][Full Text] [Related]
2. Accelerating antibody discovery using transgenic animals overexpressing the neonatal Fc receptor as a result of augmented humoral immunity.
Cervenak J; Kurrle R; Kacskovics I
Immunol Rev; 2015 Nov; 268(1):269-87. PubMed ID: 26497527
[TBL] [Abstract][Full Text] [Related]
3. FcRn Overexpression Expands Diversity of the Humoral Immune Response in bFcRn Transgenic Mice.
Szikora B; Marx A; Jani PK; Pipek O; Müller V; Csabai I; Kacskovics I
Front Immunol; 2020; 11():1887. PubMed ID: 32973781
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the rabbit neonatal Fc receptor (FcRn) and analyzing the immunophenotype of the transgenic rabbits that overexpresses FcRn.
Catunda Lemos AP; Cervenak J; Bender B; Hoffmann OI; Baranyi M; Kerekes A; Farkas A; Bosze Z; Hiripi L; Kacskovics I
PLoS One; 2012; 7(1):e28869. PubMed ID: 22247762
[TBL] [Abstract][Full Text] [Related]
5. FcRn overexpression in mice results in potent humoral response against weakly immunogenic antigen.
Végh A; Cervenak J; Jankovics I; Kacskovics I
MAbs; 2011; 3(2):173-80. PubMed ID: 21239891
[TBL] [Abstract][Full Text] [Related]
6. Transgenic rabbits that overexpress the neonatal Fc receptor (FcRn) generate higher quantities and improved qualities of anti-thymocyte globulin (ATG).
Baranyi M; Cervenak J; Bender B; Kacskovics I
PLoS One; 2013; 8(10):e76839. PubMed ID: 24194847
[TBL] [Abstract][Full Text] [Related]
7. Transgenic expression of bovine neonatal Fc receptor in mice boosts immune response and improves hybridoma production efficiency without any sign of autoimmunity.
Schneider Z; Cervenak J; Baranyi M; Papp K; Prechl J; László G; Erdei A; Kacskovics I
Immunol Lett; 2011 Jun; 137(1-2):62-9. PubMed ID: 21338624
[TBL] [Abstract][Full Text] [Related]
8. Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering.
Wang Y; Tian Z; Thirumalai D; Zhang X
J Drug Target; 2014 May; 22(4):269-78. PubMed ID: 24404896
[TBL] [Abstract][Full Text] [Related]
9. Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics.
Piche-Nicholas NM; Avery LB; King AC; Kavosi M; Wang M; O'Hara DM; Tchistiakova L; Katragadda M
MAbs; 2018 Jan; 10(1):81-94. PubMed ID: 28991504
[TBL] [Abstract][Full Text] [Related]
10. FcRn overexpression in transgenic mice results in augmented APC activity and robust immune response with increased diversity of induced antibodies.
Végh A; Farkas A; Kövesdi D; Papp K; Cervenak J; Schneider Z; Bender B; Hiripi L; László G; Prechl J; Matkó J; Kacskovics I
PLoS One; 2012; 7(4):e36286. PubMed ID: 22558422
[TBL] [Abstract][Full Text] [Related]
11. FcRn: the neonatal Fc receptor comes of age.
Roopenian DC; Akilesh S
Nat Rev Immunol; 2007 Sep; 7(9):715-25. PubMed ID: 17703228
[TBL] [Abstract][Full Text] [Related]
12. Human FcRn Transgenic Mice for Pharmacokinetic Evaluation of Therapeutic Antibodies.
Roopenian DC; Christianson GJ; Proetzel G; Sproule TJ
Methods Mol Biol; 2016; 1438():103-14. PubMed ID: 27150086
[TBL] [Abstract][Full Text] [Related]
13. NFκB induces overexpression of bovine FcRn: a novel mechanism that further contributes to the enhanced immune response in genetically modified animals carrying extra copies of FcRn.
Cervenak J; Doleschall M; Bender B; Mayer B; Schneider Z; Doleschall Z; Zhao Y; Bősze Z; Hammarström L; Oster W; Kacskovics I
MAbs; 2013; 5(6):860-71. PubMed ID: 24492342
[TBL] [Abstract][Full Text] [Related]
14. Human FcRn transgenic mice for pharmacokinetic evaluation of therapeutic antibodies.
Roopenian DC; Christianson GJ; Sproule TJ
Methods Mol Biol; 2010; 602():93-104. PubMed ID: 20012394
[TBL] [Abstract][Full Text] [Related]
15. Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice.
Kliwinski C; Cooper PR; Perkinson R; Mabus JR; Tam SH; Wilkinson TM; Giles-Komar J; Scallon B; Powers GD; Hornby PJ
Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G262-70. PubMed ID: 23220220
[TBL] [Abstract][Full Text] [Related]
16. Neonatal FcR overexpression boosts humoral immune response in transgenic mice.
Cervenak J; Bender B; Schneider Z; Magna M; Carstea BV; Liliom K; Erdei A; Bosze Z; Kacskovics I
J Immunol; 2011 Jan; 186(2):959-68. PubMed ID: 21148035
[TBL] [Abstract][Full Text] [Related]
17. Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection.
Li Z; Palaniyandi S; Zeng R; Tuo W; Roopenian DC; Zhu X
Proc Natl Acad Sci U S A; 2011 Mar; 108(11):4388-93. PubMed ID: 21368166
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration.
Smith B; Kiessling A; Lledo-Garcia R; Dixon KL; Christodoulou L; Catley MC; Atherfold P; D'Hooghe LE; Finney H; Greenslade K; Hailu H; Kevorkian L; Lightwood D; Meier C; Munro R; Qureshi O; Sarkar K; Shaw SP; Tewari R; Turner A; Tyson K; West S; Shaw S; Brennan FR
MAbs; 2018 Oct; 10(7):1111-1130. PubMed ID: 30130439
[TBL] [Abstract][Full Text] [Related]
19. Altering Antibody-Drug Conjugate Binding to the Neonatal Fc Receptor Impacts Efficacy and Tolerability.
Hamblett KJ; Le T; Rock BM; Rock DA; Siu S; Huard JN; Conner KP; Milburn RR; O'Neill JW; Tometsko ME; Fanslow WC
Mol Pharm; 2016 Jul; 13(7):2387-96. PubMed ID: 27248573
[TBL] [Abstract][Full Text] [Related]
20. A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies.
Stracke J; Emrich T; Rueger P; Schlothauer T; Kling L; Knaupp A; Hertenberger H; Wolfert A; Spick C; Lau W; Drabner G; Reiff U; Koll H; Papadimitriou A
MAbs; 2014; 6(5):1229-42. PubMed ID: 25517308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
